Sobi has a diversified and growth-oriented commercial product portfolio within three business lines: Core Products, Partner Products and ReFacto Manufacturing.
These are proprietary products or products where
Sobi has global or regional rights.
Partner Products comprise about 40 products which are commercialized on behalf of specialty and rare disease partner companies.
Sobi is the global supplier of the drug substance for ReFacto AF®/XYNTHA®, a drug sold by Pfizer for the treatment of hemophilia A.